May 23 – Gift from Mr. Taubman makes news

A new $5 million gift by philanthropist and retail pioneer A. Alfred Taubman is making news today, including a major story in the Detroit News and a story on the Michigan Associated Press wire that is being picked up by many news outlets around the state. Mr. Taubman is giving the gift to support research on amyotrophic lateral sclerosis, better known as Lou Gehrig’s disease, led by Eva Feldman, M.D., Ph.D., of Neurology. Part of the research, which will test the use of embryonic stem cells as a potential treatment for this deadly nerve disease, will be performed in collaboration with Martin Marsala, M.D., of the University of California, San Diego School of Medicine. Read the UMHS press release about the gift here.

Sept 19 – Detroit News reports on benefit gala for Dr. Feldman

A week after profiling Eva Feldman, M.D., Ph.D., Neurology, the Detroit News has followed up with a story on the benefit gala held this past weekend to raise money for her laboratory’s research on ALS, also known as Lou Gehrig’s disease.

Sept. 12 – Dr. Feldman profiled in Detroit News

The front page of the features section in today’s Detroit News contains a major profile of Eva Feldman, M.D., Ph.D., Neurology, including several photos. The article, by columnist Marney Rich Keenan, focuses on Dr. Feldman’s longtime friendship with business leader and U-M donor A. Alfred Taubman, who has been both her patient and a benefactor of her research. The article also mentions a gala event that Mr. Taubman will host this weekend, to raise money for research by Dr. Feldman’s group on amyotrophic lateral sclerosis, ALS, also known as Lou Gehrig’s disease.

Aug. 21 – Dr. Feldman in Crain’s Detroit

A major story in this week’s Crain’s Detroit Business focuses on the research of Eva Feldman, M.D., Ph.D., and the financial support she has received from major donors. The story especially looks at support for her research on ALS (Lou Gehrig’s Disease). It also promotes a fundraising event that was held on Sept.16 to raise money for her team’s work. The event is being hosted by U-M donor Alfred Taubman. The story is available online to subscribers only, or you can request the story from public relations at 734-764-2220.

March 26- Dr. Feldman in Ann Arbor News, Detroit Free Press

By coincidence, two newspapers ran major feature stories involving Eva Feldman, M.D., Ph.D., Neurology, on the same day – – giving readers across southeastern Michigan a chance to learn about her research and the clinical trials she is currently leading. In the joint Sunday edition of the Detroit Free Press and Detroit News, Free Press columnist Susan Ager wrote of her experience as a participant in Dr. Feldman’s trial for people with mild nerve damage related to Type 1 diabetes – – and along the way, educated readers about the process of taking part in clinical research. In addition to Dr. Feldman and research nurse Cynthia Plunkett, RNC, the story also quotes Dan Clauw, MD, director of the Center for the Advancement of Clinical Research, and directs readers to the Engage web site to learn more about clinical trials at U-M. The second story, in the Ann Arbor News, focused on Dr. Feldman’s research in diabetes but also in ALS (Lou Gehrig’s disease) and other nerve disorders.

Dr. Feldman on CNBC

On Sunday, Feb. 19, CNBC at 7 p.m. aired an episode of the diabetes show “dLife” featuring Eva Feldman, M.D., Ph.D., the DeJong Professor of Neurology at the U-M Medical School. Dr. Feldman discussed the latest research in diabetes, including how people with diabetes can take part in clinical trials. She was also featured in a segment on the search for a cure for diabetes. Different cable systems offer CNBC on different channels; check your provider’s listings.

The dLife TV show is a weekly television series for the diabetes community that is focused on information, inspiration, and lifestyle issues in an entertaining format. It can also be seen on satellite television, and segments are available online after their airdate at www.dlife.com.

$1 million gift to PFUND

David & Charlene Handleman of Bloomfield Hills recently made a $50,000 gift to the Program for Understanding Neurological Diseases. In making the gift, David and Charlene aim to encourage the scientists and researchers of PFUND to continue making the important contributions to neurology.

Handleman gift benefits the PFUND

David & Charlene Handleman of Bloomfield Hills recently made a $50,000 gift to the Program for Understanding Neurological Diseases. In making the gift, David and Charlene aim to encourage the scientists and researchers of PFUND to continue making the important contributions to neurology.

Pepsi and PFUND Unite Against Neurological Diseases

In an exciting new initiative to fight Lou Gehrig’s Disease (ALS) and other neurological diseases, Pepsi has handpicked the PFUND’s research to display on some 6 million soda cans. The information regarding the PFUND and its mission was exhibited on cans of Caffeine Free Diet Pepsi for the first time in August 2004. The cans were distributed once again in July 2005 throughout Southeastern Michigan. The common goal of Pepsi and the PFUND is to increase understanding of neurological diseases in Michigan and inspire support for the fight against these diseases worldwide. PFUND director, Eva Feldman, M.D., Ph.D. is optimistic that this type of mass exposure will generate funds necessary to fuel current research by PFUND investigators, scientists seeking treatments for diseases such as ALS, Childhood Cancer (tumor related to the nervous system), and Diabetes. Presently, the PFUND has raised over $1 million, roughly ten percent of the ultimate goal of $10 million. Hopefully, the partnership with Pepsi will help the PFUND reach that goal and take a big step forward in the struggle against Neurological Disease.

PFUND Student presents research on Capitol Hill

David Zhen, a U-M undergraduate, was among 60 students chosen from around the nation to present the results of his independent research on Neuroblastoma; a neurological childhood cancer, in Washington D.C. on April 19th, 2005. David has been a part of the Feldman lab for two years, working diligently under the supervision of Dr. Tracy Schwab. The event provided the students an opportunity to present their research to members of the Congress, Federal agency funding officers and invited guests. Due to David and Dr. Schwab’s excellent efforts, the Feldman lab has been chosen to be a part of the Congressional tour of research facilities in MI, scheduled for August 2005.